NCT00625768View on ClinicalTrials.gov

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
Metastatic Renal Cell CarcinomaMetastatic Malignant Melanoma
Interventions
DRUG

AS1409

Study drug

Trial Locations (4)

Unknown

Auckland Medical School, Auckland

Waikato DHB, Hamilton

SE1 9RT

Guys Hospital, London

W6 8RF

Charing Cross Hospital, London

Sponsors

Lead Sponsor

Antisoma Research
All Listed Sponsors
lead

Antisoma Research

INDUSTRY

NCT00625768 - Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma | Biotech Hunter | Biotech Hunter